PT Kimia Farma Tbk (IDX:KAEF)

Market Cap	3.06T
Revenue (ttm)	9.57T
Net Income (ttm)	-841.72B
Shares Out	5.57B
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,392,400
Average Volume	3,436,275
Open	555.00
Previous Close	550.00
Day's Range	535.00 - 560.00
52-Week Range	324.00 - 905.00
Beta	1.47
RSI	44.95
Earnings Date	Aug 14, 2025

About Accolade

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products in Indonesia, Saudi Arabia, the United States, the Netherlands, the United Kingdom, China, Malaysia, and internationally. The company operates through the Manufacturing, Distribution, Retail, and Other segments. It provides generic, ethical, licensed, and narcotic medicines; over-the-counter medicines and herbs; tablets, injections, syrups, raw materials, medical devices, and cosmetic products. The company is also involved in research and development activities,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1817
• Employees: 5,946
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KAEF

Financial Performance

In 2024, PT Kimia Farma Tbk's revenue was 9.94 trillion, an increase of 0.68% compared to the previous year's 9.87 trillion. Losses were -842.27 billion, -57.12% less than in 2023.